- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03717597
Nonrandomized Evaluation of a Multidimensional Behavioral Intervention (BBLite)
A Nonrandomized Evaluation of a Multidimensional Behavioral Intervention for Those at Risk for Alzheimer's Dementia
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Sacramento, California, United States, 95816
- University of California Davis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- a diagnosis of subjective cognitive complaints (SCC)
- Age 65+
- English speaking
- Available informant to complete surveys
- Ambulatory
Exclusion Criteria:
- Known neurological condition
- Severe psychiatric illness (e.g., current depression)
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Participants will complete an initial assessment within 2 weeks prior to starting the course or during the first class.
The course will include 10 sessions conducted on a weekly basis.
Following completion of the course, participants will again complete another assessment during the last class or within 2 weeks of course completion.
Participants may be invited to complete assessments at 3- and 6-months following course completion.
|
Subjects will attend a series of 2 hour classes, once a week for 10 weeks. Topics discussed in group sessions will cover compensation strategies (e.g., calendar, goal setting and task lists, functional zones) and brain health behaviors (e.g., exercise, cognitive activity, stress reduction and mindfulness). Subjects may be asked to wear an actigraphy monitor (that looks like a wrist watch) and/or heart rate sensor that is designed to collect information regarding physical activity. |
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in compensation use
Time Frame: baseline and 6 months follow up
|
Measured using the Everyday Compensation Questionnaire, a 54-item self-report questionnaire that asks participants how often they engage in a variety of activities that help them stay cognitively and physically active.
|
baseline and 6 months follow up
|
|
Change in cognition
Time Frame: baseline and 6 months follow up
|
Measured using the Everyday Cognition (ECog) scale, a self-rated questionnaire of cognitively-based everyday abilities.
The ECog comprises of 39 items on which the participant's current level of everyday functioning is compared to 10 years earlier.
Items are rated on a four-point scale: 1= better or no change compared to 10 years earlier; 4= consistently much worse.
Higher scores indicate greater functional limitations.
|
baseline and 6 months follow up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Beck Depression Inventory
Time Frame: baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
Measures depressive symptomatology
|
baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
|
Beck Anxiety Inventory
Time Frame: baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
measures anxiety symptomatology
|
baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
|
List learning task
Time Frame: baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
measures learning and memory
|
baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
|
Executive function task
Time Frame: baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
measures executive function
|
baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
|
Psychomotor Speed Task
Time Frame: baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
measures psychomotor function
|
baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
|
GRIT
Time Frame: baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
8-item questionnaire assessing consistency of interest and perseverance of effort on a five-point scale: 1 = not at all like me, 5 = very much like me.
|
baseline, immediately after intervention, and 3 and 6 month follow-up visits
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Michelle Chan, PhD, University of California, Davis
Publications and helpful links
General Publications
- Tomaszewski Farias S, Schmitter-Edgecombe M, Weakley A, Harvey D, Denny KG, Barba C, Gravano JT, Giovannetti T, Willis S. Compensation Strategies in Older Adults: Association With Cognition and Everyday Function. Am J Alzheimers Dis Other Demen. 2018 May;33(3):184-191. doi: 10.1177/1533317517753361. Epub 2018 Jan 23.
- Farias ST, Lau K, Harvey D, Denny KG, Barba C, Mefford AN. Early Functional Limitations in Cognitively Normal Older Adults Predict Diagnostic Conversion to Mild Cognitive Impairment. J Am Geriatr Soc. 2017 Jun;65(6):1152-1158. doi: 10.1111/jgs.14835. Epub 2017 Mar 17.
- Greenaway MC, Duncan NL, Smith GE. The memory support system for mild cognitive impairment: randomized trial of a cognitive rehabilitation intervention. Int J Geriatr Psychiatry. 2013 Apr;28(4):402-9. doi: 10.1002/gps.3838. Epub 2012 Jun 7.
- Greenaway MC, Hanna SM, Lepore SW, Smith GE. A behavioral rehabilitation intervention for amnestic mild cognitive impairment. Am J Alzheimers Dis Other Demen. 2008 Oct-Nov;23(5):451-61. doi: 10.1177/1533317508320352.
- Lau KM, Parikh M, Harvey DJ, Huang CJ, Farias ST. Early Cognitively Based Functional Limitations Predict Loss of Independence in Instrumental Activities of Daily Living in Older Adults. J Int Neuropsychol Soc. 2015 Oct;21(9):688-98. doi: 10.1017/S1355617715000818. Epub 2015 Sep 22.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 1210286
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.